Carregant...
New Progress of Epigenetic Biomarkers in Urological Cancer
Urological cancers consist of bladder, kidney, prostate, and testis cancers and they are generally silenced at their early stage, which leads to the loss of the best opportunity for early diagnosis and treatment. Desired biomarkers are scarce for urological cancers and current biomarkers are lack of...
Guardat en:
| Publicat a: | Dis Markers |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Hindawi Publishing Corporation
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4993951/ https://ncbi.nlm.nih.gov/pubmed/27594736 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/9864047 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|